As a component of the Alabama Center for Childhood Cancer and Blood Disorders, the Developmental Therapeutics Program is a partnership between the UAB Division of Pediatric Hematology/Oncology and Children's of Alabama. This innovative program provides access to cutting-edge experimental treatments that are not widely available. By participating in developmental therapeutics studies, patients receive state-of-the-art care while helping to advance the treatment of pediatric cancers.
The Developmental Therapeutics Program is undertaking clinical trials of therapies such as targeted anti-cancer molecules, new chemotherapies, immunostimulatory therapy and even cancer fighting viruses--among many others. We give careful consideration to determine which study is the most appropriate for each child, their family, and the child's cancer.
Pediatric oncology patients from across the Southeast come to Birmingham for the compassionate care offered by Children's of Alabama. The Developmental Therapeutics Program brings together top clinicians, researchers, patients, and their families. Together we study the newest, most promising therapies made possible through discoveries of the UAB Comprehensive Cancer Center and researchers around the world.
Treating Kids, not just cancer
Our patients range from infants to young adults and are diagnosed with a variety of cancer types, but they all have two things in common. The first is that the cancer they face lacks any proven curative options. The second is that they have the strength of the UAB Comprehensive Cancer Center's world-renowned researchers and clinicians working to find a treatment for their cancer. We offer novel therapies for children diagnosed with neuroblastoma, brain tumors, sarcomas, and other difficult-to-treat solid tumors, as well as relapsed leukemias and lymphomas. The therapies we study now will lead to advances in the treatment of pediatric cancers in the future. Regardless of the patient's diagnosis, each child is treated as an individual - not a disease.